{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:12:05Z","timestamp":1793927525116,"version":"4.8.0"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"The Eve Appeal charity","id":[{"id":"https:\/\/ror.org\/01t825428","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Barts Cancer Institute Cancer Research","id":[{"id":"https:\/\/ror.org\/0266wrt04","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","award":["C16420\/A18066"],"award-info":[{"award-number":["C16420\/A18066"]}],"id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1093\/jnci\/djx265","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T15:13:29Z","timestamp":1511363609000},"page":"714-725","source":"Crossref","is-referenced-by-count":166,"title":["Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women"],"prefix":"10.1093","volume":"110","author":[{"given":"Ranjit","family":"Manchanda","sequence":"first","affiliation":[{"name":"Centre for Experimental Cancer Medicine, Queen Mary University of London, London, UK"},{"name":"Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK"},{"name":"Gynaecological Cancer Research Centre, Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeya","family":"Patel","sequence":"additional","affiliation":[{"name":"Centre for Experimental Cancer Medicine, Queen Mary University of London, London, UK"},{"name":"Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir S","family":"Gordeev","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis C","family":"Antoniou","sequence":"additional","affiliation":[{"name":"Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantel","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lee","sequence":"additional","affiliation":[{"name":"Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Hopper","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"MacInnis","sequence":"additional","affiliation":[{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Turnbull","sequence":"additional","affiliation":[{"name":"Barts Cancer Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J","family":"Ramus","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, School of Women\u2019s and Children\u2019s Health, University of New South Wales, Sydney, Australia"},{"name":"The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A","family":"Gayther","sequence":"additional","affiliation":[{"name":"Cedars Sinai Medical Centre, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D P","family":"Pharoah","sequence":"additional","affiliation":[{"name":"Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Menon","sequence":"additional","affiliation":[{"name":"Gynaecological Cancer Research Centre, Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Gynaecological Cancer Research Centre, Department of Women\u2019s Cancer, Institute for Women\u2019s Health, University College London, London, UK"},{"name":"University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Legood","sequence":"additional","affiliation":[{"name":"Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t20180708200036_djx265-B1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA."},{"issue":"2","key":"key\n\t\t\t\t20180708200036_djx265-B2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"key\n\t\t\t\t20180708200036_djx265-B3","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol."},{"issue":"9880","key":"key\n\t\t\t\t20180708200036_djx265-B4","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: An updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet."},{"issue":"6","key":"key\n\t\t\t\t20180708200036_djx265-B5","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/humrep\/dem055","article-title":"Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer","volume":"22","author":"Menon","year":"2007","journal-title":"Hum Reprod."},{"issue":"7","key":"key\n\t\t\t\t20180708200036_djx265-B6","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/sj.bjc.6603358","article-title":"Evaluation of models to predict BRCA germline mutations","volume":"95","author":"Kang","year":"2006","journal-title":"Br J Cancer."},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jnci\/dju379","article-title":"Population testing for cancer predisposing BRCA1\/BRCA2 mutations in the Ashkenazi-Jewish community: A randomized controlled trial","volume":"107","author":"Manchanda","year":"2015","journal-title":"J Natl Cancer Inst."},{"issue":"39","key":"key\n\t\t\t\t20180708200036_djx265-B8","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.1415979111","article-title":"Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2","volume":"111","author":"Gabai-Kapara","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"key\n\t\t\t\t20180708200036_djx265-B9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2009.25.0712","article-title":"Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women","volume":"28","author":"Metcalfe","year":"2010","journal-title":"J Clin Oncol."},{"issue":"5","key":"key\n\t\t\t\t20180708200036_djx265-B10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ng.2224","article-title":"Germline RAD51C mutations confer susceptibility to ovarian cancer","volume":"44","author":"Loveday","year":"2012","journal-title":"Nat Genet."},{"issue":"9","key":"key\n\t\t\t\t20180708200036_djx265-B11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","article-title":"Germline mutations in RAD51D confer susceptibility to ovarian cancer","volume":"43","author":"Loveday","year":"2011","journal-title":"Nat Genet."},{"issue":"11","key":"key\n\t\t\t\t20180708200036_djx265-B12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.955","article-title":"Mutations in BRIP1 confer high risk of ovarian cancer","volume":"43","author":"Rafnar","year":"2011","journal-title":"Nat Genet."},{"issue":"11","key":"key\n\t\t\t\t20180708200036_djx265-B13","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv214","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"J Natl Cancer Inst."},{"issue":"26","key":"key\n\t\t\t\t20180708200036_djx265-B14","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","article-title":"Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population","volume":"33","author":"Song","year":"2015","journal-title":"J Clin Oncol."},{"issue":"9","key":"key\n\t\t\t\t20180708200036_djx265-B15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jmedgenet-2016-103800","article-title":"Defining the risk threshold of premenopausal risk reducing salpingo-oophorectomy for ovarian cancer prevention: A cost-effectiveness analysis","volume":"53","author":"Manchanda","year":"2016","journal-title":"J Med Genet."},{"issue":"3","key":"key\n\t\t\t\t20180708200036_djx265-B16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2015.10.001","article-title":"Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women","volume":"139","author":"Manchanda","year":"2015","journal-title":"Gynecol Oncol."},{"issue":"6","key":"key\n\t\t\t\t20180708200036_djx265-B17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N Engl J Med."},{"issue":"11","key":"key\n\t\t\t\t20180708200036_djx265-B18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1586\/14737140.2015.1090879","article-title":"Genetic risk assessment and prevention: The role of genetic testing panels in breast cancer","volume":"15","author":"Lerner-Ellis","year":"2015","journal-title":"Expert Rev Anticancer Ther."},{"key":"key\n\t\t\t\t20180708200036_djx265-B19","volume-title":"NICE Clinical Guideline.","author":"NICE","year":"2013","edition":"CG164"},{"issue":"10","key":"key\n\t\t\t\t20180708200036_djx265-B20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nbt1486","article-title":"Next-generation DNA sequencing","volume":"26","author":"Shendure","year":"2008","journal-title":"Nat Biotechnol."},{"issue":"44","key":"key\n\t\t\t\t20180708200036_djx265-B21","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jnci\/dju380","article-title":"Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing","volume":"107","author":"Manchanda","year":"2015","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"key\n\t\t\t\t20180708200036_djx265-B23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/fon.15.278","article-title":"Genetic screening for gynecological cancer: Where are we heading?","volume":"12","author":"Manchanda","year":"2016","journal-title":"Future Oncol."},{"issue":"7","key":"key\n\t\t\t\t20180708200036_djx265-B24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jmedgenet-2015-103740","article-title":"Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1\/2 mutations","volume":"53","author":"Manchanda","year":"2016","journal-title":"J Med Genet."},{"issue":"7","key":"key\n\t\t\t\t20180708200036_djx265-B25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1200\/JCO.2013.51.3226","article-title":"Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer","volume":"32","author":"Schwartz","year":"2014","journal-title":"J Clin Oncol."},{"issue":"4","key":"key\n\t\t\t\t20180708200036_djx265-B26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet Gynecol."},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause."},{"key":"key\n\t\t\t\t20180708200036_djx265-B28","volume-title":"Guide to the Methods of Technology Appraisal.","author":"National Institute for Health and Clinical Excellence","year":"2008","edition":"N1618"},{"issue":"7","key":"key\n\t\t\t\t20180708200036_djx265-B29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103077","article-title":"A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects","volume":"52","author":"Jervis","year":"2015","journal-title":"J Med Genet."},{"key":"key\n\t\t\t\t20180708200036_djx265-B30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41523-017-0024-8","article-title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","volume":"3","author":"Slavin","year":"2017","journal-title":"NPJ Breast Cancer."},{"key":"key\n\t\t\t\t20180708200036_djx265-B31","author":"Department of Health","year":"2013"},{"key":"key\n\t\t\t\t20180708200036_djx265-B32","volume-title":"Unit Costs of Health and Social Care 2011.","author":"Curtis","year":"2011"},{"key":"key\n\t\t\t\t20180708200036_djx265-B33","author":"Office of National Statistics"},{"issue":"11","key":"key\n\t\t\t\t20180708200036_djx265-B34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"key\n\t\t\t\t20180708200036_djx265-B35","author":"CRUK","year":"2014"},{"key":"key\n\t\t\t\t20180708200036_djx265-B36","author":"SEER","year":"2014"},{"key":"key\n\t\t\t\t20180708200036_djx265-B37","author":"SEER","year":"2014"},{"key":"key\n\t\t\t\t20180708200036_djx265-B38","volume-title":"Social Value Judgements: Principles for the Development of NICE Guidance.","author":"NICE","year":"2008","edition":"2nd"},{"issue":"14","key":"key\n\t\t\t\t20180708200036_djx265-B39","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.163.14.1637","article-title":"What is the price of life and why doesn't it increase at the rate of inflation?","volume":"163","author":"Ubel","year":"2003","journal-title":"Arch Intern Med."},{"issue":"9","key":"key\n\t\t\t\t20180708200036_djx265-B40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med."},{"issue":"29","key":"key\n\t\t\t\t20180708200036_djx265-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13290","article-title":"Sensitivity analysis in economic evaluation: An audit of NICE current practice and a review of its use and value in decision-making","volume":"13","author":"Andronis","year":"2009","journal-title":"Health Technol Assess."},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1524-4733.2005.08101.x","article-title":"Probabilistic analysis of cost-effectiveness models: Statistical representation of parameter uncertainty","volume":"8","author":"Briggs","year":"2005","journal-title":"Value Health."},{"issue":"9","key":"key\n\t\t\t\t20180708200036_djx265-B43","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamaoncol.2015.2340","article-title":"Cost-effectiveness of universal BRCA1\/2 screening: Evidence-based decision making","volume":"1","author":"Long","year":"2015","journal-title":"JAMA Oncol."},{"issue":"3","key":"key\n\t\t\t\t20180708200036_djx265-B44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2015.10.001","article-title":"Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women","volume":"139","author":"Manchanda","year":"2015","journal-title":"Gynecol Oncol."},{"issue":"11","key":"key\n\t\t\t\t20180708200036_djx265-B45","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/sj.bjc.6605965","article-title":"Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition","volume":"103","author":"Tsilidis","year":"2010","journal-title":"Br J Cancer."},{"issue":"5","key":"key\n\t\t\t\t20180708200036_djx265-B46","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/1055-9965.EPI-10-1325","article-title":"Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort","volume":"20","author":"Brinton","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"15","key":"key\n\t\t\t\t20180708200036_djx265-B47","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol."},{"key":"key\n\t\t\t\t20180708200036_djx265-B48","author":"PROMISE","year":"2016"},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol Oncol."},{"issue":"28","key":"key\n\t\t\t\t20180708200036_djx265-B50","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J Clin Oncol."},{"issue":"22","key":"key\n\t\t\t\t20180708200036_djx265-B51","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J Clin Oncol."},{"issue":"2","key":"key\n\t\t\t\t20180708200036_djx265-B52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0090-8258(03)00072-6","article-title":"Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy","volume":"89","author":"Robson","year":"2003","journal-title":"Gynecol Oncol."},{"issue":"7","key":"key\n\t\t\t\t20180708200036_djx265-B53","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2011.02920.x","article-title":"Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status","volume":"118","author":"Manchanda","year":"2011","journal-title":"BJOG."},{"issue":"13","key":"key\n\t\t\t\t20180708200036_djx265-B54","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA."},{"issue":"31","key":"key\n\t\t\t\t20180708200036_djx265-B55","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol."},{"issue":"22","key":"key\n\t\t\t\t20180708200036_djx265-B56","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst."},{"issue":"6","key":"key\n\t\t\t\t20180708200036_djx265-B57","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.AOG.0000450757.18294.cf","article-title":"Committee Opinion No. 601: Tamoxifen and uterine cancer","volume":"123","year":"2014","journal-title":"Obstet Gynecol."},{"key":"key\n\t\t\t\t20180708200036_djx265-B58","author":"RCOG","year":"2016"},{"issue":"2","key":"key\n\t\t\t\t20180708200036_djx265-B59","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx159","article-title":"Risk of serous endometrial carcinoma in women with pathogenic BRCA1\/2 variant after risk-reducing salpingo-oophorectomy","volume":"110","author":"Saule","year":"2018","journal-title":"J Natl Cancer Inst."},{"issue":"11","key":"key\n\t\t\t\t20180708200036_djx265-B60","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol."},{"issue":"2","key":"key\n\t\t\t\t20180708200036_djx265-B61","doi-asserted-by":"crossref","first-page":"218, e1","DOI":"10.1016\/j.ajog.2007.08.075","article-title":"Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths","volume":"198","author":"Ueda","year":"2008","journal-title":"Am J Obstet Gynecol."},{"issue":"3","key":"key\n\t\t\t\t20180708200036_djx265-B62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ygyno.2017.03.025","article-title":"Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous\/serous-like uterine cancers in BRCA1 mutation carriers","volume":"145","author":"Havrilesky","year":"2017","journal-title":"Gynecol Oncol."},{"key":"key\n\t\t\t\t20180708200036_djx265-B63","article-title":"Commentary on changing the risk threshold for surgical prevention of ovarian cancer","author":"Manchanda","journal-title":"BJOG."},{"issue":"9","key":"key\n\t\t\t\t20180708200036_djx265-B64","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA."},{"issue":"9","key":"key\n\t\t\t\t20180708200036_djx265-B65","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv217","article-title":"RE: Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: Revisiting the evidence for risk reduction","volume":"107","author":"Chai","year":"2015","journal-title":"J Natl Cancer Inst."},{"issue":"5","key":"key\n\t\t\t\t20180708200036_djx265-B66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/WHE.09.42","article-title":"Effect of bilateral oophorectomy on women's long-term health","volume":"5","author":"Parker","year":"2009","journal-title":"Womens Health (Lond Engl)."},{"issue":"5","key":"key\n\t\t\t\t20180708200036_djx265-B67","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv033","article-title":"Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: Revisiting the evidence for risk reduction","volume":"107","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"J Natl Cancer Inst."},{"issue":"24","key":"key\n\t\t\t\t20180708200036_djx265-B68","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1200\/JCO.2007.13.9568","article-title":"Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: A prospective 1-year follow-up study","volume":"26","author":"Brandberg","year":"2008","journal-title":"J Clin Oncol."},{"issue":"10","key":"key\n\t\t\t\t20180708200036_djx265-B69","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bjps.2007.08.006","article-title":"Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction","volume":"61","author":"Isern","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"key\n\t\t\t\t20180708200036_djx265-B70","volume-title":"Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.","author":"Nelson","year":"2013"},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejso.2011.10.010","article-title":"Less correspondence between expectations before and cosmetic results after risk-reducing mastectomy in women who are mutation carriers: A prospective study","volume":"38","author":"Brandberg","year":"2012","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pon.726","article-title":"Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy","volume":"13","author":"Metcalfe","year":"2004","journal-title":"Psychooncology"},{"issue":"4","key":"key\n\t\t\t\t20180708200036_djx265-B73","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2354.2010.01204.x","article-title":"High satisfaction rate ten years after bilateral prophylactic mastectomy - a longitudinal study","volume":"20","author":"Wasteson","year":"2011","journal-title":"Eur J Cancer Care (Engl)"},{"key":"key\n\t\t\t\t20180708200036_djx265-B74","author":"Genomics England","year":"2015"},{"issue":"20","key":"key\n\t\t\t\t20180708200036_djx265-B75","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMp1600894","article-title":"Aiming high--changing the trajectory for cancer","volume":"374","author":"Lowy","year":"2016","journal-title":"N Engl J Med."},{"issue":"2","key":"key\n\t\t\t\t20180708200036_djx265-B76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1355819615622655","article-title":"Using institutional theory to analyse hospital responses to external demands for finance and quality in five European countries","volume":"21","author":"Burnett","year":"2016","journal-title":"J Health Serv Res Policy."},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B77","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13012-016-0445-z","article-title":"Explaining outcomes in major system change: A qualitative study of implementing centralised acute stroke services in two large metropolitan regions in England","volume":"11","author":"Fulop","year":"2016","journal-title":"Implement Sci."},{"issue":"5","key":"key\n\t\t\t\t20180708200036_djx265-B78","doi-asserted-by":"crossref","first-page":"578.e1","DOI":"10.1016\/j.ajog.2017.06.038","article-title":"Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry","volume":"217","author":"Manchanda","year":"2017","journal-title":"Am J Obstet Gynecol."},{"issue":"8","key":"key\n\t\t\t\t20180708200036_djx265-B79","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008-2030): A population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol."},{"key":"key\n\t\t\t\t20180708200036_djx265-B80","author":"International Agency for Research on Cancer","year":"2016"},{"key":"key\n\t\t\t\t20180708200036_djx265-B81","author":"The Health Foundation","year":"2015"},{"issue":"8","key":"key\n\t\t\t\t20180708200036_djx265-B82","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-09-0171","article-title":"Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent","volume":"18","author":"Evans","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"8","key":"key\n\t\t\t\t20180708200036_djx265-B83","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.bjc.6604305","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancers: Updates and extensions","volume":"98","author":"Antoniou","year":"2008","journal-title":"Br J Cancer."},{"issue":"11","key":"key\n\t\t\t\t20180708200036_djx265-B84","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol."},{"key":"key\n\t\t\t\t20180708200036_djx265-B85","author":"CRUK","year":"2015"},{"key":"key\n\t\t\t\t20180708200036_djx265-B86","author":"SEER","year":"2016"},{"issue":"5","key":"key\n\t\t\t\t20180708200036_djx265-B87","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","article-title":"Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: A competing risk time to event analysis","volume":"119","author":"Manchanda","year":"2012","journal-title":"BJOG."},{"issue":"5","key":"key\n\t\t\t\t20180708200036_djx265-B88","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol."},{"issue":"2","key":"key\n\t\t\t\t20180708200036_djx265-B89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1258\/mi.2010.010023","article-title":"Compliance with estrogen hormone replacement therapy after oophorectomy: A prospective study","volume":"16","author":"Read","year":"2010","journal-title":"Menopause Int."},{"issue":"1","key":"key\n\t\t\t\t20180708200036_djx265-B90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","article-title":"Tamoxifen for prevention of breast cancer: Extended long-term follow-up of the IBIS-I breast cancer prevention trial","volume":"16","author":"Cuzick","year":"2015","journal-title":"Lancet Oncol."},{"issue":"4","key":"key\n\t\t\t\t20180708200036_djx265-B91","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/annonc\/mdv590","article-title":"Factors affecting uptake and adherence to breast cancer chemoprevention: A systematic review and meta-analysis","volume":"27","author":"Smith","year":"2016","journal-title":"Ann Oncol."},{"issue":"10","key":"key\n\t\t\t\t20180708200036_djx265-B92","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.30498","article-title":"A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes","volume":"123","author":"Buys","year":"2017","journal-title":"Cancer."},{"key":"key\n\t\t\t\t20180708200036_djx265-B93","volume-title":"Jews in Britain: A Snapshot From the 2001 Census.","author":"Graham","year":"2007"},{"key":"key\n\t\t\t\t20180708200036_djx265-B94","first-page":"182","volume-title":"Census 2001: National report for England and Wales, Part 1, Section 2. Table S149: Sex and age by religion.","author":"Office of National Statistics","year":"2003"},{"key":"key\n\t\t\t\t20180708200036_djx265-B95","year":"2017"},{"key":"key\n\t\t\t\t20180708200036_djx265-B96","author":"Pew Research Center","year":"2013"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/110\/7\/714\/25124829\/djx265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T13:01:31Z","timestamp":1570366891000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/110\/7\/714\/4816906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":96,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,1,18]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djx265","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,1,18]]}}}